CVS Health Corp. CVS
NYSE · Healthcare · Medical - Healthcare Plans
$80.84
Close on Fri, 20 Nov 2026 · market value $103B
What the price is betting on
Below its recordAt $81, the price assumes revenue shrinks about 19% a year for five years, from $421B to about $176B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.6% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than CVS? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$253
Base
$284
Bull
$317
Today $81
- Bear $253. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $284. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $317. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$399B$422B, on the path
- FY2027$325B$433B, on the path
- FY2028$265B$452B, on the path
- FY2029$216B$483B, on the path
- FY2030$176B$502B, on the path
Each year's revenue at −19% growth from $421B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Healthcare Plans · listed on NYSE
- Revenue, FY2025
- $402B
- Growth, 3 years a year
- 6.1%
- Cash margin
- 1.9%
- Net debt
- $69.4B
- Shares, 3-year change
- −3.9%
- Dividend yield
- 3.3%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.